Data / Form D filings / ADIAL PHARMACEUTICALS, INC.
ADIAL PHARMACEUTICALS, INC.: Form D filings
ADIAL PHARMACEUTICALS, INC., a pharmaceuticals company in Glen Allen, VA, filed 19 Form D notices with the SEC between 2011 and 2025. The latest, on December 3, 2025, reports $4.3 million sold of a $4.3 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4870 SADLER ROAD, SUITE 300, Glen Allen, VA, 23060
- Phone
- (804) 487-8196
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1513525
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 3, 2025 | New notice | $4,285,289 | $4,285,289 | 1 | Nov 28, 2025 | sec.gov | |
| May 14, 2025 | New notice | $4,815,379 | $4,815,379 | 1 | May 2, 2025 | sec.gov | |
| Mar 14, 2024 | New notice | $287,500 | $287,500 | 1 | Mar 6, 2024 | sec.gov | |
| Oct 26, 2023 | New notice | $3,998,582 | $3,998,582 | 1 | Oct 19, 2023 | sec.gov | |
| Jun 5, 2023 | New notice | $3,052,500 | $52,500 | $3,000,000 | 1 | May 31, 2023 | sec.gov |
| Mar 6, 2023 | New notice | $61,603 | $61,603 | 1 | Feb 23, 2023 | sec.gov | |
| Feb 17, 2022 | New notice | $10,000,000 | $10,000,000 | 1 | Feb 11, 2022 | sec.gov | |
| Jul 12, 2021 | New notice | $5,000,000 | $500,004 | $4,499,996 | 3 | Jul 6, 2021 | sec.gov |
| Mar 26, 2021 | New notice | $2,100,003 | $291,003 | $1,809,000 | 5 | Mar 11, 2021 | sec.gov |
| Nov 30, 2020 | New notice | $15,295,750 | $295,750 | $15,000,000 | 1 | Nov 18, 2020 | sec.gov |
| Sep 25, 2020 | New notice | $500,000 | $500,000 | 1 | Sep 21, 2020 | sec.gov | |
| Jun 17, 2020 | New notice | $5,217,000 | $5,217,000 | 6 | Jun 9, 2020 | sec.gov | |
| Jun 14, 2018 | New notice | $325,000 | $325,000 | 1 | Jun 3, 2018 | sec.gov | |
| Mar 13, 2018 | New notice | $500,000 | $500,000 | 7 | Feb 23, 2018 | sec.gov | |
| Dec 5, 2017 | New notice | $100,000 | $100,000 | 5 | Nov 21, 2017 | sec.gov | |
| Aug 31, 2017 | New notice | $40,000 | $40,000 | 2 | Jun 11, 2017 | sec.gov | |
| May 16, 2017 | New notice | $287,500 | $287,500 | 1 | May 1, 2017 | sec.gov | |
| Oct 2, 2013 | New notice | $3,000,000 | $2,631,042 | $368,958 | 35 | Jun 30, 2013 | sec.gov |
| Mar 16, 2011 | New notice | $4,100,000 | $4,100,000 | 0 | Mar 11, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| James W. Newman, Jr. | Director | |
| James K. Anderson | Director | |
| Vinay J. Shah | Executive Officer | |
| Robertson H. Gilliland | Director | |
| Tony W. Goodman | Executive Officer, Director | |
| Kevin W. Schuyler, CFA | Director | |
| Cary J. Claiborne | Executive Officer, Director |
Other pharmaceuticals companies in Virginia that filed recently
- Quoin Pharmaceuticals Ltd. $50 million · Sep 10, 2026
Every Form D from the week of Dec 1, 2025 · All recent filings in Virginia · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what ADIAL PHARMACEUTICALS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.